S
SquareMind
Creating autonomous robots that will help healthcare professionals save time and improve patient care
About SquareMind
Developer of robotic medical equipment designed to transform non-invasive healthcare. The company's medical equipment is equipped with third-dimension construction software for full-body mapping to detect skin cancer, enabling physicians to track the growth of moles on the body using off-the-shelf robots. Keywords: Healthcare Devices, Services, Supplies, Cancer Detection, Cancer Detection Equipment, Medical Equipment, Oncology Device, Oncology Robots, Robotics Medical Equipment.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 82.8/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Dermatology, Core AI, Health Diagnostics, EIC
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning, Computer Vision
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Apr 2026 | $18M | $72M | Adamed Group · Calm/Storm Ventures · Bpifrance · Sonder Capital | ↗ |
| SEED✓Equity / VC | Jun 2023 | — | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SquareMind is 50 monthly website visits, down 73.7% over the last three months. SquareMind's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
id4 Ventures
Entrepreneurs First
Calm/Storm Ventures
European Innovation Council
Series A4 investors entered at this stage
Adamed Group
Bpifrance
Sonder Capital
Teampact Ventures
Other known investors2 additional known investors
EIT Health
Alban Oudin
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SquareMind on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SquareMind’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







